Diuretics induce magnesium deficiency: tactics of correction


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article discusses magnesium-excreting effects of the main classes of diuretics (loop diuretics, thiazide diuretics, potassium-sparing diuretics, and others.), and their relationship with unwanted side effects of therapy. The similarity between certain congenital kidney dysfunctions and iatrogenic effects of diuretics is established. The prospects of the use of magnesium-containing drugs for the compensation of hypomagnesemia, hypokalemia and other negative effects of therapy with diuretics are demonstrated.

Texto integral

Acesso é fechado

Sobre autores

Olga Gromova

Ivanovo state medical academy

Email: unesco.gromova@gmail.com
MD, professor of the Department of pharmacology and clinical pharmacology

Tatiana Grishina

Ivanovo state medical academy

MD, professor, head of the Department of pharmacology and clinical pharmacology

Ivan Torshin

Moscow institute of physics and technology (state university)

candidate of physico-mathematical sciences, associate professor of the Department of intelligent systems

Olga Limanova

Ivanovo state medical academy

PhD, associated professor of the Department of pharmacology and clinical pharmacology

Nataliya Yudina

Ivanovo state medical academy

postgraduate student of the Department of pharmacology and clinical pharmacology

Alla Kalacheva

Ivanovo state medical academy

PhD, associated professor of the Department of pharmacology and clinical pharmacology

Bibliografia

  1. Kawamura Y. Drugs affecting serum magnesium concentration. Clin. Calcium. 2012;22(8):1211-6.
  2. Lameris A.L., Monnens L.A., Bindels R.J., Hoenderop J.G. Drug-induced alterations in Mg2+ homoeostasis. Clin. Sci. (Lond). 2012;123(1):1-14.
  3. Achhammer I., Metz P. Low dose loop diuretics in essential hypertension. Experience with torasemide. Drugs. 1991;41(Suppl. 3):80-91.
  4. Khow K.S., Lau S.Y., Li J.Y., Yong T.Y. Diuretic-associated electrolyte disorders in the elderly: risk factors, impact, management and prevention. Curr. Drug Saf. 2014;9(1):2-15.
  5. Wile D. Diuretics: a review. Ann. Clin. Biochem. 2012;49(Pt 5):419-31.
  6. Classen H.G., Grober U., Kisters K. Drug-induced magnesium deficiency. Med. Monatsschr. Pharm. 2012;35(8):274-80.
  7. Громова О.А., Калачева А.Г., Торшин И.Ю. Недостаточность магния - достоверный фактор риска коморбидных состояний: результаты крупномасштабного скрининга магниевого статуса в регионах России. Фарматека. 2013;6(259):115-29. [Gromova O.A., Kalacheva A.G., Torshin I Yu. Deficiency of magnesium - a significant risk factorof comorbid conditions: results of a large-scale screening of magnesium status in the regions of Russia. Pharmateca. 2013;6(259):115-29 (in Russ.)]
  8. Громова О.А., Торщин И.Ю., Лиманова О.А., Гоголева И.В. Анализ взаимосвязи между обеспеченностью магнием и риском соматических заболеваний у россиянок 18-45 лет методами интеллектуального анализа данных. Эффективная фармакотерапия. Акушерство и гинекология. 2014;2:10-23. [Gromova O.A., Torshin I.Yu., Limanova A.O., Gogoleva I.V. Analysis of the relationship between the availability of magnesium and risk of somatic diseases in women 18-45 years with data mining methods. Effective pharmacotherapy. Obstetrics and gynecology. 2014;2:10-23 (in Russ.)]
  9. Sarafidis P.A., Georgianos P.I., Lasaridis A.N. Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy. Expert Opin. Drug Saf. 2010;9(2):259-73.
  10. Greger R., Lohrmann E., Schlatter E. Action of diuretics at the cellular level. Clin. Nephrol. 1992;38 (Suppl. 1):S64-S68.
  11. Quamme G.A. Renal handling of magnesium: drug and hormone interactions. Magnesium. 1986;5(5-6):248-72.
  12. Greger R., Wangemann P. Loop diuretics. Ren. Physiol. 1987;10(3-4):174-83.
  13. Tamargo J., Segura J., Ruilope L.M. Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents. Expert Opin. Pharmacother. 2014;15(5):605-21.
  14. Kim N., Cheema-Dhadli S., Hare G.M., Chong C.K., Halperin M.L., Kamel K.S., Mazer C.D. Non-natriuretic doses of furosemide: potential use for decreasing the workload of the renal outer medulla with minimal magnesium wasting in the rat. Nephron Physiol. 2012;122(1-2):7-12.
  15. Dai L.J., Ritchie G., Kerstan D., Kang H.S., Cole D.E., Quamme G.A. Magnesium transport in the renal distal convoluted tubule. Physiol. Rev. 2001;81(1):51-84.
  16. Nijenhuis T., Vallon V., van der Kemp A.W., Loffing J., Hoenderop J.G., Bindels R.J. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J. Clin. Invest. 2005;115(6):1651-8.
  17. Labeeuw M., Pozet N., Zech P., Hadj-Aissa A., Sassard J. Magnesuria induced by thiazides and the influence of triamterene. Fundam. Clin. Pharmacol. 1987;1(3):225-32.
  18. Kieboom B.C., Kiefte-de Jong J.C., Eijgelsheim M., Franco O.H., Kuipers E.J., Hofman A., Zietse R., Stricker B.H., Hoorn E.J. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am. J. Kidney Dis. 2015;66(5):775-82.
  19. Danziger J., William J.H., Scott D.J., Lee J., Lehman L.W., Mark R.G., Howell M.D., Celi L.A., Mukamal K.J. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013;83(4):692-9.
  20. Martin-Miguel V., Lafarga-Giribets M.A., Garcia-Esteve L., Rodrigo-Claverol M.D. Casual diagnosis of Gitelman's syndrome. Semergen. 2014;40(7):e95-8.
  21. Kurschat C., Heering P., Grabensee B. Gitelman's syndrome: an important differential diagnosis of hypokalemia. Dtsch. Med. Wochenschr. 2003;128(22):1225-8.
  22. Colussi G., Rombola G., Airaghi C., De Ferrari M.E., Minetti L. Pseudo-Bartter's syndrome from surreptitious diuretic intake: differential diagnosis with true Bartter's syndrome. Nephrol. Dial. Transplant. 1992;7(9):896-901.
  23. Prichard B.N., Owens C.W., Woolf A.S. Adverse reactions to diuretics. Eur. Heart J. 1992;13 (Suppl G):96-103.
  24. Greenberg A. Diuretic complications. Am. J. Med. Sci. 2000;319(1):10-24.
  25. Joao Matias P., Azevedo A., Laranjinha I., Navarro D., Mendes M., Ferreira C., Amaral T., Jorge C., Aires I., Gil C., Ferreira A. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients. Blood Purif. 2014;38(3-4):244-52.
  26. Soliman H.M., Mercan D., Lobo S.S., Melot C., Vincent J.L. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit. Care Med. 2003;31(4):1082-7.
  27. Torshin I.Yu., Gromova O.A. Magnesium and pyridoxine: fundamental studies and clinical practice. Nova Science Publ., 2011. 196 p.
  28. Sheehan J., White A. Diuretic-associated hypomagnesaemia. Br. Med. J. (Clin. Res. Ed). 1982;285(6349):1157-9.
  29. Cunha A.R., Medeiros F., Umbelino B., Oigman W., Touyz R.M., Neves M.F. Altered vascular structure and wave reflection in hypertensive women with low magnesium levels. J. Am. Soc. Hypertens. 2013;7(5):344-52.
  30. Reyes A.J., Leary W.P. Diuretic therapy, magnesium deficiency and lipid metabolism. S. Afr. Med. J. 1983;64(10):355-6.
  31. Dyckner T., Wester P.O. Effect of magnesium on blood pressure. Br. Med. J (Clin. Res. Ed). 1983;286(6381):1847-9.
  32. Sotornik I., Schuck O. Effect of single dose of diuretics on renal magnesium excretion in man, with special reference to their site of action. Physiol. Bohemoslov. 1976;25(3):207-12.
  33. Hollifield J.W. Thiazide treatment of systemic hypertension: effects on serum magnesium and ventricular ectopic activity. Am. J. Cardiol. 1989;63(14):22G-25G.
  34. Громова О.А., Торшин И.Ю., Калачева А.Г., Гришина Т.Р. О синергизме калия и магния в поддержании функции миокарда. Кардиология. 2016;3:73-80. [Gromova O.A., Torshin I.Yu., Kalacheva A.G., Grishina T.R. Synergism of potassium and magnesium in maintaining myocardial function. Kardiologiia. 2016;3:73-80 (in Russ.)]
  35. Morita H., Wu J., Zipes D.P. The QT syndromes: long and short. Lancet. 2008;372(9640):750-63.
  36. Kramer B.K., Endemann D. Cardiac risks of hypokalemia and hypomagnesemia. Ther. Umsch. 2000;57(6):398-9.
  37. Громова О.А., Калачева А.Г., Торшин И.Ю., Гришина Т.Р., Юдина Н.В. Калийсберегающие свойства магния. Кардиология. 2013;53(10):38-48. [Gromova O.A., Kalacheva A.G., Torshin I.Yu., Grishina T.R., Yudina N.V. Potassium-sparing properties of magnesium. Kardiologiia. 2013;53(10):38-48 (in Russ.)]
  38. Wester P.O., Dyckner T. Problems with potassium and magnesium in diuretic-treated patients. Acta. Pharmacol. Toxicol (Copenh). 1984;54 (Suppl. 1):59-65.
  39. Dorup I., Skajaa K., Clausen T., Kjeldsen K. Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics. Br. Med. J. (Clin. Res. Ed). 1988;296(6620):455-8.
  40. Reyes A.J. Renal excretory profiles of loop diuretics: consequences for therapeutic application. J. Cardiovasc. Pharmacol. 1993;22 (Suppl. 3):S11-S23.
  41. Knauf H., Mutschler E., Velazquez H., Giebisch G. Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis. Eur. J. Clin. Pharmacol. 2009;65(5):465-72.
  42. Cohen N., Alon I., Almoznino-Sarafian D., Zaidenstein R., Weissgarten J., Gorelik O., Berman S., Modai D., Golik A. Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. Clin. Cardiol. 2000;23(6):433-6.
  43. Odvina C.V., Mason R.P., Pak C.Y. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. Am. J. Ther. 2006;13(2):101-8.
  44. Ruml L.A., Gonzalez G., Taylor R., Wuermser L.A., Pak C.Y. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Am. J. Ther. 1999;6(1):45-50.
  45. Ruml L.A., Wuermser L.A., Poindexter J., Pak C.Y. The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. J. Clin. Pharmacol. 1998;38(1 1):1035-41.
  46. Dorup I., Skajaa K., Thybo N.K. Oral magnesium supplementation to patients receiving diuretics-normalization of magnesium, potassium and sodium, and potassium pumps in the skeletal muscles. Ugeskr. Laeger. 1994;156(27):4007-10, 4013.
  47. Paolisso G., Di Maro G., Cozzolino D., Salvatore T., D'Amore A., Lama D., Varricchio M., D'Onofrio F. Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients. Am. J. Hypertens. 1992;5(10):681-6.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies